
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Prepared to a prescriber's order for one patient. Not FDA-approved.
This is a compounded capsule containing cholesterol, prepared to a prescriber's order for one patient. Compounded preparations are not FDA-approved.
These listings cover every salt or ester form of each drug in the FDA National Drug Code Directory.
No FDA-approved (NDA or ANDA) product containing cholesterol is listed. Products containing it are filed in the directory as homeopathic products, in liquid, pellet, solution and spray forms. None of the listed products containing cholesterol is in capsule form.
This is a solid, nonaqueous dose form. Under USP <795>, nonaqueous preparations carry longer default beyond-use dates than water-containing ones. The date printed on the label is the one to follow.
Cholesterol is a natural skin and cell membrane lipid used in compounding as a base ingredient and emollient in topical creams, sometimes alongside other actives.
Cholesterol is the principal sterol of higher animals. In the body it is the starting material for steroid hormones, bile acids and provitamin D3, and in the skin it is one of the lipids that give the outer layer its barrier function. Pharmaceutical-grade cholesterol is a National Formulary (USP-NF) article refined from sheep wool grease, supplied as a white, oil-soluble, water-insoluble powder and used as a pharmaceutic aid: an emulsifying agent, emollient and emulsion stabilizer in creams and ointments and a structural lipid in liposomal drug carriers. There is no FDA-approved cholesterol drug; the only cholesterol-labeled products in DailyMed are homeopathic. Prescribers may order a compounded cream in which cholesterol is included as a component, for example together with lovastatin, when they want a topical preparation that no manufacturer makes. Compounded preparations are not FDA-approved and require a prescription.
Cholesterol as a topical ingredient has no FDA drug label, so there is no boxed warning, contraindication list or drug interaction list to report, and it is described for external use only. Pharmaceutical cholesterol is refined from sheep wool grease. A 2020 case series of a compounded cholesterol and lovastatin cream for porokeratosis reported no adverse effects over up to three months of twice-daily use. Stop use and talk to your prescriber or pharmacist if a cream causes redness, itching or rash. Applying a cream that contains cholesterol is unrelated to blood cholesterol and is not a treatment for high cholesterol. No drug label or lactation database entry addresses topical cholesterol in pregnancy or breastfeeding, so ask your prescriber or pharmacist.
Cholesterol is the end product of the mevalonate pathway and a structural lipid of stratum corneum lamellar bilayers. NF-grade material is a lanolin-derived sterol with cholesterol content specified at 95 percent or more and total sterols 97 to 102 percent, stabilized with alpha-tocopherol, and the Hazardous Substances Data Bank classifies it as a pharmaceutic aid (emulsifying agent); it is also used as a lipid component of liposomes that carry chemotherapeutic drugs. Systemic pharmacokinetic data for topical application are limited, and there is no labeled indication. Prescribers have ordered compounded cholesterol with lovastatin for porokeratosis: Atzmony et al. (J Am Acad Dermatol 2020;82:123-131) treated five patients with mevalonate pathway (MVD or PMVK) mutations twice daily for up to three months and reported near complete clearance of disseminated superficial actinic porokeratosis lesions with the combination but not with cholesterol alone, moderate improvement in linear and palmoplantar disseminated types, and no adverse effects, while noting the small uncontrolled design. The stated rationale is replacing cholesterol the mutated pathway fails to make while lovastatin blocks accumulation of toxic upstream metabolites. Concentration and vehicle per prescriber. Monitoring: local tolerability.
Swallow each capsule whole with a glass of water, unless your label says otherwise. Do not crush, chew or open the capsule unless your pharmacist tells you it is safe to do so. Take it at the times shown on your prescription label. If you miss a dose or are unsure how to take it, call the pharmacy.
Capsules are nonaqueous, so under USP <795> they usually carry a beyond-use date of up to 180 days when no other stability data apply. Keep the vial tightly closed at room temperature, away from heat, moisture and direct light, and out of reach of children. Discard any capsules left after the beyond-use date on the label.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth